Terms: = Brain cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Treatment
6 results:
1. Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
Ling AL; Solomon IH; Landivar AM; Nakashima H; Woods JK; Santos A; Masud N; Fell G; Mo X; Yilmaz AS; Grant J; Zhang A; Bernstock JD; Torio E; Ito H; Liu J; Shono N; Nowicki MO; Triggs D; Halloran P; Piranlioglu R; Soni H; Stopa B; Bi WL; Peruzzi P; Chen E; Malinowski SW; Prabhu MC; Zeng Y; Carlisle A; Rodig SJ; Wen PY; Lee EQ; Nayak L; Chukwueke U; Gonzalez Castro LN; Dumont SD; Batchelor T; Kittelberger K; Tikhonova E; Miheecheva N; Tabakov D; Shin N; Gorbacheva A; Shumskiy A; Frenkel F; Aguilar-Cordova E; Aguilar LK; Krisky D; Wechuck J; Manzanera A; Matheny C; Tak PP; Barone F; Kovarsky D; Tirosh I; Suvà ML; Wucherpfennig KW; Ligon K; Reardon DA; Chiocca EA
Nature; 2023 Nov; 623(7985):157-166. PubMed ID: 37853118
[TBL] [Abstract] [Full Text] [Related]
2. Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study.
Di Maio M; Bighin C; Schettini F; Ruelle T; Marandino L; Fabi A; De Angelis C; Giuliano M; De Placido P; De Laurentiis M; Riccardi F; Picotto C; Puglisi F; Del Mastro L; Arpino G;
Breast; 2023 Dec; 72():103583. PubMed ID: 37783133
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas.
Li J; Wang J; Ding Y; Zhao J; Wang W
BMC Cancer; 2022 Apr; 22(1):466. PubMed ID: 35484511
[TBL] [Abstract] [Full Text] [Related]
4. Sedation practices in pediatric patients with acute lymphoblastic leukemia.
Nugent BD; Davis PJ; Noll RB; Tersak JM
Pediatr Blood Cancer; 2020 Feb; 67(2):e28037. PubMed ID: 31625677
[TBL] [Abstract] [Full Text] [Related]
5. mnx1 reduces sensitivity to anoikis by activating TrkB in human glioma cells.
Jiang L; Chen S; Zhao D; Yan J; Chen J; Yang C; Zheng G
Mol Med Rep; 2018 Sep; 18(3):3271-3279. PubMed ID: 30066929
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.
Auer TA; Breit HC; Marini F; Renovanz M; Ringel F; Sommer CJ; Brockmann MA; Tanyildizi Y
J Neuroradiol; 2019 Feb; 46(1):36-43. PubMed ID: 29733920
[TBL] [Abstract] [Full Text] [Related]
